112 related articles for article (PubMed ID: 15571970)
1. Noninvasive in vivo whole body luminescent analysis of luciferase labelled orthotopic prostate tumours.
El Hilali N; Rubio N; Blanco J
Eur J Cancer; 2004 Dec; 40(18):2851-8. PubMed ID: 15571970
[TBL] [Abstract][Full Text] [Related]
2. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
El Hilali N; Rubio N; Blanco J
Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196
[TBL] [Abstract][Full Text] [Related]
3. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging.
Brutkiewicz S; Mendonca M; Stantz K; Comerford K; Bigsby R; Hutchins G; Goebl M; Harrington M
Luminescence; 2007; 22(3):221-8. PubMed ID: 17286245
[TBL] [Abstract][Full Text] [Related]
4. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence: imaging modality for in vitro and in vivo gene expression.
Sadikot RT; Blackwell TS
Methods Mol Biol; 2008; 477():383-94. PubMed ID: 19082962
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice.
Zhang AL; Russell PJ
Cancer Lett; 2006 Feb; 233(1):185-91. PubMed ID: 15927363
[TBL] [Abstract][Full Text] [Related]
7. Photoactivable bioluminescent probes for imaging luciferase activity.
Shao Q; Jiang T; Ren G; Cheng Z; Xing B
Chem Commun (Camb); 2009 Jul; (27):4028-30. PubMed ID: 19568622
[TBL] [Abstract][Full Text] [Related]
8. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
[TBL] [Abstract][Full Text] [Related]
9. Extended-release PEG-luciferin allows for long-term imaging of firefly luciferase activity in vivo.
Chandran SS; Williams SA; Denmeade SR
Luminescence; 2009; 24(1):35-8. PubMed ID: 18780328
[TBL] [Abstract][Full Text] [Related]
10. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.
Bloquel C; Trollet C; Pradines E; Seguin J; Scherman D; Bureau MF
BMC Biotechnol; 2006 Mar; 6():16. PubMed ID: 16524461
[TBL] [Abstract][Full Text] [Related]
11. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.
Peter C; Kielstein JT; Clarke-Katzenberg R; Adams MC; Pitsiouni M; Kambham N; Karimi MA; Kengatharan KM; Cooke JP
J Urol; 2007 Jun; 177(6):2342-6. PubMed ID: 17509355
[TBL] [Abstract][Full Text] [Related]
12. Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging.
Buckle T; van Leeuwen FW
Lab Anim; 2010 Jan; 44(1):40-5. PubMed ID: 19854758
[TBL] [Abstract][Full Text] [Related]
13. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
14. Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays.
Shinde R; Perkins J; Contag CH
Biochemistry; 2006 Sep; 45(37):11103-12. PubMed ID: 16964971
[TBL] [Abstract][Full Text] [Related]
15. Building Biological Flashlights: Orthogonal Luciferases and Luciferins for
Williams SJ; Prescher JA
Acc Chem Res; 2019 Nov; 52(11):3039-3050. PubMed ID: 31593431
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive imaging of firefly luciferase reporter gene expression using bioluminescence imaging in human prostate cancer models.
Li H; Li JZ; Helm GA; Pan D
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):179-84. PubMed ID: 17073822
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
Yazici S; Kim SJ; Busby JE; He J; Thaker P; Yokoi K; Fan D; Fidler IJ
Prostate; 2005 Nov; 65(3):203-15. PubMed ID: 15948138
[TBL] [Abstract][Full Text] [Related]
18. Cage the firefly luciferin! - a strategy for developing bioluminescent probes.
Li J; Chen L; Du L; Li M
Chem Soc Rev; 2013 Jan; 42(2):662-76. PubMed ID: 23099531
[TBL] [Abstract][Full Text] [Related]
19. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene.
Park SY; Wang X; Chen Z; Powers AC; Magnuson MA; Head WS; Piston DW; Bell GI
Genesis; 2005 Oct; 43(2):80-6. PubMed ID: 16108006
[TBL] [Abstract][Full Text] [Related]
20. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
Lang T; Goyard S; Lebastard M; Milon G
Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
